Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells

The idea that conversion of glucose to ATP is an attractive target for cancer therapy has been supported in part by the observation that glucose deprivation induces apoptosis in rodent cells transduced with the proto-oncogene MYC, but not in the parental line. Here, we found that depletion of glucose killed normal human cells irrespective of induced MYC activity and by a mechanism different from apoptosis. However, depletion of glutamine, another major nutrient consumed by cancer cells, induced apoptosis depending on MYC activity. This apoptosis was preceded by depletion of the Krebs cycle intermediates, was prevented by two Krebs cycle substrates, but was unrelated to ATP synthesis or several other reported consequences of glutamine starvation. Our results suggest that the fate of normal human cells should be considered in evaluating nutrient deprivation as a strategy for cancer therapy, and that understanding how glutamine metabolism is linked to cell viability might provide new approaches for treatment of cancer.

[1]  P. Gaynon,et al.  Deamination of glutamine is a prerequisite for optimal asparagine deamination by asparaginases in vivo (CCG-1961). , 2004, Anticancer research.

[2]  H. Forman,et al.  Buthionine sulphoximine alone and in combination with melphalan (L-PAM) is highly cytotoxic for human neuroblastoma cell lines. , 1997, European journal of cancer.

[3]  B. Fuchs,et al.  Stressing out over survival: glutamine as an apoptotic modulator. , 2006, The Journal of surgical research.

[4]  L. Reitzer,et al.  Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. , 1979, The Journal of biological chemistry.

[5]  R. Curi,et al.  Molecular mechanisms of glutamine action , 2005, Journal of cellular physiology.

[6]  E. Rogakou,et al.  DNA Double-stranded Breaks Induce Histone H2AX Phosphorylation on Serine 139* , 1998, The Journal of Biological Chemistry.

[7]  J. Matés,et al.  Co-expression of glutaminase K and L isoenzymes in human tumour cells. , 2005, The Biochemical journal.

[8]  M. Tomita,et al.  Quantitative metabolome analysis using capillary electrophoresis mass spectrometry. , 2003, Journal of proteome research.

[9]  R. Hebbel,et al.  alpha-Ketoacids scavenge H2O2 in vitro and in vivo and reduce menadione-induced DNA injury and cytotoxicity. , 1995, The American journal of physiology.

[10]  G. Friedell,et al.  The proportionality of glutaminase content to growth rate and morphology of rat neoplasms. , 1969, Cancer research.

[11]  H. Morris,et al.  Glutaminase activities and growth rates of rat hepatomas. , 1969, Cancer research.

[12]  W. Zong,et al.  How do cancer cells acquire the fuel needed to support cell growth? , 2005, Cold Spring Harbor symposia on quantitative biology.

[13]  Eyal Gottlieb,et al.  Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. , 2005, Cancer cell.

[14]  R. D. De Abreu,et al.  Reversal of methylmercaptopurine ribonucleoside cytotoxicity by purine ribonucleosides and adenine. , 1995, Biochemical pharmacology.

[15]  M. Simpson,et al.  Structural Insights into Histone Demethylation by JMJD2 Family Members , 2006, Cell.

[16]  R. L. Hawkins,et al.  Lactate: A major product of glutamine metabolism by human diploid fibroblasts , 1980, Journal of cellular physiology.

[17]  K. Wirtz,et al.  "Wages of fear": transient threefold decrease in intracellular ATP level imposes apoptosis. , 2004, Biochimica et biophysica acta.

[18]  D. Green,et al.  The Pathophysiology of Mitochondrial Cell Death , 2004, Science.

[19]  J. Grem,et al.  Metabolism and action of amino acid analog anti-cancer agents. , 1990, Pharmacology & therapeutics.

[20]  O. H. Lowry,et al.  The measurement of pyridine nucleotides by enzymatic cycling. , 1961, The Journal of biological chemistry.

[21]  E. Prochownik,et al.  MYC oncogenes and human neoplastic disease , 1999, Oncogene.

[22]  Hans Ulrich Bergmeyer,et al.  Methods of Enzymatic Analysis , 2019 .

[23]  A. Ladurner,et al.  Rheostat control of gene expression by metabolites. , 2006, Molecular cell.

[24]  Z. Kovačević Possibility for the transfer of reducing equivalents from the cytosol to the mitochondrial compartment in Ehrlich ascites tumor cells by the malate-aspartate shuttle. , 1972, European journal of biochemistry.

[25]  M. Butler,et al.  Profile of energy metabolism in a murine hybridoma: Glucose and glutamine utilization , 1994, Journal of cellular physiology.

[26]  J. Cleveland,et al.  c-Myc Augments Gamma Irradiation-Induced Apoptosis by Suppressing Bcl-XL , 2003, Molecular and Cellular Biology.

[27]  H. R. Zielke,et al.  Glutamine: a major energy source for cultured mammalian cells. , 1984, Federation proceedings.

[28]  Z. Kovačević,et al.  Control and function of the transamination pathways of glutamine oxidation in tumour cells. , 1991, The Biochemical journal.

[29]  G. Hannon,et al.  MaRX: An Approach to Genetics in Mammalian Cells , 1999, Science.

[30]  S. Pelengaris,et al.  The many faces of c-MYC. , 2003, Archives of biochemistry and biophysics.

[31]  M. Eilers,et al.  Transcriptional regulation and transformation by Myc proteins , 2005, Nature Reviews Molecular Cell Biology.

[32]  L. Baggetto,et al.  Deviant energetic metabolism of glycolytic cancer cells. , 1992, Biochimie.

[33]  R. DePinho,et al.  The LKB1 tumor suppressor negatively regulates mTOR signaling. , 2004, Cancer cell.

[34]  P. Hammerman,et al.  Beginnings of a signal-transduction pathway for bioenergetic control of cell survival. , 2004, Trends in biochemical sciences.

[35]  S. Schreiber,et al.  Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[36]  C. Townsend,et al.  Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells. , 2003, Cancer research.

[37]  A. Meister,et al.  Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). , 1979, The Journal of biological chemistry.

[38]  C. Dang,et al.  Deregulation of Glucose Transporter 1 and Glycolytic Gene Expression by c-Myc* , 2000, The Journal of Biological Chemistry.

[39]  David G. Watson,et al.  Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. , 2005, Cancer cell.

[40]  C. Nathan,et al.  Secretion of pyruvate. An antioxidant defense of mammalian cells , 1987, The Journal of experimental medicine.

[41]  T. Turkington,et al.  Clinical applications of PET in oncology. , 2004, Radiology.

[42]  L. Reitzer,et al.  The continuous growth of vertebrate cells in the absence of sugar. , 1981, The Journal of biological chemistry.

[43]  M. Loda,et al.  c-Myc phosphorylation is required for cellular response to oxidative stress. , 2006, Molecular cell.

[44]  B Crabtree,et al.  The role of high rates of glycolysis and glutamine utilization in rapidly dividing cells , 1985, Bioscience reports.

[45]  S. Fulda,et al.  HIF-1-Regulated Glucose Metabolism: A Key to Apoptosis Resistance? , 2007, Cell cycle.

[46]  W. Souba,et al.  Molecular and functional analysis of glutamine uptake in human hepatoma and liver-derived cells. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[47]  A. Lehninger,et al.  The pathways of glutamate and glutamine oxidation by tumor cell mitochondria. Role of mitochondrial NAD(P)+-dependent malic enzyme. , 1984, The Journal of biological chemistry.

[48]  L. Kaczmarek,et al.  Proapoptotic N-truncated BCL-xL protein activates endogenous mitochondrial channels in living synaptic terminals. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[49]  M. Guppy,et al.  Cancer metabolism: facts, fantasy, and fiction. , 2004, Biochemical and biophysical research communications.

[50]  N. Sonenberg,et al.  Translational control in stress and apoptosis , 2005, Nature Reviews Molecular Cell Biology.

[51]  G. Evan,et al.  A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. , 1995, Nucleic acids research.

[52]  C. Sen,et al.  Flow cytometric determination of cellular thiols. , 1999, Methods in enzymology.

[53]  W. Ho,et al.  A convenient one-step extraction of cellular ATP using boiling water for the luciferin-luciferase assay of ATP. , 2002, Analytical biochemistry.

[54]  Y. Lazebnik,et al.  Oncogene-dependent apoptosis is mediated by caspase-9. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[55]  G. Wahl,et al.  c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. , 2002, Molecular cell.

[56]  Didier Picard,et al.  Chimaeras of Myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells , 1989, Nature.

[57]  Kathryn A. O’Donnell,et al.  Myc Stimulates Nuclearly Encoded Mitochondrial Genes and Mitochondrial Biogenesis , 2005, Molecular and Cellular Biology.

[58]  C. Dang,et al.  A unique glucose-dependent apoptotic pathway induced by c-Myc. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[59]  P. Guérin,et al.  Oxidative stress is not required for the induction of apoptosis upon glutamine starvation of Sp2/0-Ag14 hybridoma cells. , 2006, European journal of cell biology.

[60]  Y. Lazebnik,et al.  Caspases Disrupt the Nuclear-Cytoplasmic Barrier , 2000, The Journal of cell biology.

[61]  S. Williams,et al.  A comparison of cell and tissue extraction techniques using high‐resolution 1H‐NMR spectroscopy , 2002, NMR in biomedicine.

[62]  S. Grimm,et al.  The tumor suppressor cybL, a component of the respiratory chain, mediates apoptosis induction. , 2003, Molecular biology of the cell.

[63]  Fionnuala Morrish,et al.  c-MYC apoptotic function is mediated by NRF-1 target genes. , 2003, Genes & development.

[64]  S. Nagata,et al.  Involvement of an ICE-like protease in Fas-mediated apoptosis , 1995, Nature.

[65]  D. Sabatini mTOR and cancer: insights into a complex relationship , 2006, Nature Reviews Cancer.

[66]  Ken Garber,et al.  Energy Deregulation: Licensing Tumors to Grow , 2006, Science.

[67]  John M Sedivy,et al.  A Large Scale Genetic Analysis of c-Myc-regulated Gene Expression Patterns* 210 , 2003, The Journal of Biological Chemistry.

[68]  M. Löffler,et al.  Uridine, but not cytidine can sustain growth of Ehrlich ascites tumor cells in glucose-deprived medium with altered proliferation kinetics. , 1985, European journal of cell biology.

[69]  L. Cantley,et al.  Ras, PI(3)K and mTOR signalling controls tumour cell growth , 2006, Nature.

[70]  O. Warburg [Origin of cancer cells]. , 1956, Oncologia.

[71]  M. Medina,et al.  Glutamine and cancer. , 2001, The Journal of nutrition.

[72]  P. Bouillet,et al.  Bim is a suppressor of Myc-induced mouse B cell leukemia. , 2004, Proceedings of the National Academy of Sciences of the United States of America.